Cargando…
Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice
Viscum album L. extracts (VE) are applied as complementary cancer therapeutics for more than one century. Extracts contain several compounds like mistletoe lectins (ML) 1-3 and viscotoxins, but also several minor ingredients. Since ML-1 has been described as one of the main active components harbori...
Autores principales: | Schötterl, Sonja, Huber, Stephan M., Lentzen, Hans, Mittelbronn, Michel, Naumann, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129785/ https://www.ncbi.nlm.nih.gov/pubmed/30224928 http://dx.doi.org/10.1155/2018/3928572 |
Ejemplares similares
-
Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma In Vitro and In Vivo in Glioblastoma Bearing Mice
por: Schötterl, Sonja, et al.
Publicado: (2019) -
Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas
por: Podlech, Oliver, et al.
Publicado: (2012) -
Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes
por: Bassoy, Esen Yonca, et al.
Publicado: (2016) -
Irradiation enhances the therapeutic effect of the oncolytic adenovirus XVir-N-31 in brain tumor initiating cells
por: Czolk, Rebecca, et al.
Publicado: (2019) -
YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells
por: Mantwill, Klaus, et al.
Publicado: (2013)